Skip to main navigation
About Axsome
About Axsome
About Axsome
All
All
Overview
Management Team
Board of Directors
Intellectual Property
State Disclosures
Portfolio
Portfolio
Portfolio
All
All
Products Overview
Products Overview
Products Overview
All
All
Overview
Sunosi
®
(solriamfetol)
Pipeline Overview
Pipeline Overview
Pipeline Overview
All
All
Overview
AXS-05
AXS-07
AXS-12
AXS-14
Conditions
Conditions
Conditions
All
All
Overview
Depression
Migraine
Alzheimer’s
Disease Agitation
Excessive Daytime
Sleepiness
Narcolepsy
Fibromyalgia
Smoking Cessation
Science
Science
Science
All
All
Overview
Medical Information U.S.
Medical Information International
Publications
Investors
Investors
Investors
All
All
Overview
Corporate Governance
Stock Information
Financial Information
News & Events
Webcasts &
Presentations
Analyst Coverage
Shareholder Services
Email Alerts
Careers
Careers
Careers
All
All
Overview
Current Opportunities
Event Details
Event
Details
Event Details
News Releases
Events
Axsome Third Quarter 2024 Financial Results
November 12, 2024 at 8:00 AM EST
Click here for webcast
